P
Proov
Health Tech & Medtech · Boulder, United States · Founded 2016
Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG MoreLess
Proov is a healthcare company specializing in medical-quality diagnostic testing aimed at enhancing fertility and overall hormone health for women. Founded by Dr. Amy Beckley and Ellen Schell, the company offers a range of products including fertility tests, supplements, and comprehensive support services. Proov primarily serves women who are trying to conceive, those experiencing hormonal imbalances, and healthcare providers in the fertility sector. Operating in the women's health market, Proov's business model revolves around direct-to-consumer sales through their website, leveraging e-commerce to reach a broad audience. Revenue is generated through the sale of diagnostic tests, supplements, and subscription-based support services. The company differentiates itself by offering scientifically-backed, easy-to-use home testing kits that provide actionable insights into hormone levels, particularly focusing on the progesterone metabolite PdG, which is crucial for successful ovulation and pregnancy outcomes. Proov's mission is to empower women by providing them with the tools and knowledge to take control of their reproductive health.
Keywords: fertility, hormone health, diagnostic testing, women's health, progesterone, ovulation, e-commerce, supplements, direct-to-consumer, reproductive health.
Company overview
Proov company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Boulder, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 31.1
Valuation & funding
Proov funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ANGEL✓Equity / VC | Apr 2024 | — | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Dec 2021 | $9.7M | $39M | GingerBread Capital · Lightship Capital · Hambrecht Ducera Growth Ventures · Portfolia Funds | ↗ |
| OtherOther financing | Nov 2021 | $0 | — | Undisclosed | — |
| GRANTOther financing | Feb 2021 | $260K | — | US National Science Foundation | ↗ |
| SEEDEquity / VC | Aug 2020 | $0 | — | Undisclosed | — |
| OtherOther financing | Sep 2019 | Undisclosed | ↗ | ||
| SEEDEquity / VC | Aug 2018 | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $2.1M | 0% | 16 |
| 2025 | $2.1M | 0% | 21 |
| 2024 | $2.1M | 0% | 23 |
| 2023 | $2.1M | +60.3% | 25 |
| 2022 | $1.3M | — | 19 |
Growth signals
Proov website traffic
Latest recorded traffic for Proov is 170K monthly website visits, up 54.5% over the last three months. Proov's team declined 23.8% over the past year.
Comparisons
Proov compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Proov's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on Proov's cap table
Sourced from Dealroom's funding and investor records.








Global footprint
Where Proov has talent and traffic
team presence
In the news
Latest news about Proov
Recent press, funding announcements, and product moves mentioning Proov — open to read from the original sources.
Market sentiment
What the market is saying about Proov
An AI-synthesized read of the highest-engagement posts about Proov on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Proov’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







